
Dr. Heidi Queen, MD | Energize Health & Hormones
Dr. Heidi Queen takes a comprehensive approach to women’s health that extends well beyond treating individual menopause symptoms. Bone health is an important part of that picture—particularly because the years surrounding menopause can bring a surprisingly rapid change in the skeleton, often before a woman has any indication that something is happening.
Osteoporosis is often described as a “silent” disease because there may be no symptoms until a fracture occurs. But the story of bone health is more complicated than simply waiting for a DXA scan to cross the osteoporosis threshold. For women in midlife, understanding how bone changes during menopause—and identifying individual risk early—can provide an opportunity to be proactive rather than reactive.
Why does bone loss accelerate around menopause?
Bone is living tissue. Throughout life, old bone is continuously broken down and replaced with new bone through a process called remodeling. Estrogen plays an important role in maintaining that balance. As ovarian hormone production changes during the menopause transition, bone resorption can accelerate. This does not necessarily begin on the day a woman has her final menstrual period. In fact, research presented through The Menopause Society describes a period of relatively rapid bone loss beginning in the years surrounding the final menstrual period and continuing for several years afterward. That makes perimenopause an important time to start thinking about bone health—not because every woman needs medication or a bone scan, but because individual risk factors can help determine who may benefit from earlier evaluation.
Is a DXA score the whole story?
A DXA, or dual-energy X-ray absorptiometry scan, is the standard test used to measure bone mineral density. The familiar T-score compares bone density with that of a healthy young adult population. A T-score between -1.0 and -2.5 is generally classified as osteopenia, while a T-score of -2.5 or lower meets the bone-density definition of osteoporosis. But a T-score is not a complete measurement of bone strength.
Bone architecture, previous fractures, age, body weight, family history, medications, medical conditions and other factors all contribute to fracture risk. The Menopause Society has also highlighted newer approaches such as trabecular bone scoring, which can provide additional information about the structure of bone beyond bone mineral density alone. This distinction matters because having osteopenia does not automatically mean that a woman is destined to develop osteoporosis—and having a relatively reassuring DXA result does not necessarily mean fracture risk is zero. The goal is to understand the whole clinical picture.
When should a woman have a bone-density scan?
There isn’t one age at which every woman suddenly needs a DXA. For women 65 and older, screening is generally recommended. For younger postmenopausal women, the decision is based more heavily on individual risk factors and whether knowing the result would change management. Earlier assessment may be appropriate for women with factors such as a previous fracture, low body weight, a family history of hip fracture or osteoporosis, smoking, certain medical conditions, premature menopause, or medications that can accelerate bone loss.
A history of significant nutritional restriction or an eating disorder during the years when peak bone mass was being established may also be relevant. Most peak bone mass is accumulated by early adulthood, so the foundation laid in the teens and twenties can influence skeletal health decades later. In other words, “I’m only 50” doesn’t tell us enough. Neither does “my mother had osteoporosis.” Good bone care starts with understanding the individual’s history.
Does estrogen protect bone?
Yes. Estrogen has an important role in maintaining bone density, and systemic menopausal hormone therapy has been shown to prevent bone loss and reduce fracture risk. The Menopause Society recognizes protection against bone loss and fractures as one of the benefits of systemic hormone therapy. This is particularly relevant during the menopause transition, when the loss of estrogen’s protective effect contributes to accelerated bone remodeling. But that does not mean every woman should take hormone therapy specifically for her bones.
Hormone therapy is a medical decision that should take into account age, timing of menopause, symptoms, personal and family history, cardiovascular and breast health, blood-clot risk, and other individual factors. For women who are appropriate candidates, the potential benefits can extend beyond symptom relief; for others, a different approach to bone protection may be more appropriate.
Does more estrogen mean stronger bones?
Not necessarily. There is considerable discussion online about hormone doses, estrogen levels and bone protection. The more useful clinical question is not “How much estrogen can I take?” but rather “What treatment is appropriate for my individual situation?”
Evidence supports the bone-protective effect of systemic estrogen, but hormone therapy should be prescribed at an appropriate dose and regimen for the individual’s symptoms, health history and treatment goals. More is not automatically better, and blood estrogen levels do not provide a simple target that can be used to determine whether someone’s bones are adequately protected. This is one reason individualized menopause care matters. Bone health is part of the larger picture rather than an isolated hormone number.
What if hormone therapy isn’t right for me?
Women should not feel that declining or being unable to use hormone therapy means they have run out of options. There are several effective medications specifically designed to reduce fracture risk in women with osteoporosis or sufficiently high fracture risk. These include antiresorptive medications such as bisphosphonates and denosumab, as well as anabolic or bone-building therapies for selected women at very high risk. The choice depends on the degree of bone loss, fracture history, other medical conditions, previous treatments and the individual’s overall risk profile.
For some women, treatment may focus primarily on preventing further loss. For others, particularly those who have already experienced a fragility fracture or have very low bone density, more intensive therapy may be appropriate. The important point is that osteoporosis is treatable—and treatment does not begin and end with hormones.
What about exercise, protein and nutrition?
Lifestyle still matters enormously, although it is important to be realistic about what lifestyle measures can and cannot accomplish. Weight-bearing activity and resistance training provide mechanical stimulation that helps maintain the musculoskeletal system. Strength and balance work also matter because preventing falls is an important part of preventing fractures.
Adequate protein, calcium, vitamin D and overall nutritional intake provide the raw materials needed for maintaining bone and muscle. A nutrient-dense eating pattern that includes vegetables, fruit, legumes, whole grains, dairy or appropriate alternatives, nuts, seeds, fish and other protein sources can support both skeletal and metabolic health.
For women losing significant weight, nutritional and muscle preservation deserve particular attention. Rapid or substantial weight loss can involve loss of lean mass as well as fat, and maintaining muscle strength becomes increasingly important with age. This is also where menopause care becomes broader than simply looking at a DXA report. Bone, muscle, hormones, nutrition and metabolic health are interconnected.
What about supplements?
Calcium and vitamin D have important roles in skeletal health, but more supplementation is not necessarily better. Ideally, nutritional needs should be evaluated in the context of diet, medical history, medications and individual risk. Supplements can be useful when dietary intake is inadequate or a deficiency exists, but they should complement—not replace—appropriate screening, exercise, nutrition and medical treatment when treatment is indicated.
The same principle applies to the many supplements marketed specifically for “bone support.” Some have promising preliminary evidence, but that is different from demonstrating that a supplement prevents fractures or treats osteoporosis. When bone health is at stake, evidence and individualized assessment matter more than an impressive supplement label.
The bigger question: What is your fracture risk?
Perhaps the most useful way to think about bone health is to move beyond the question, “Is my T-score normal?” The better questions are:
- How much bone do I have?
- How quickly am I losing it?
- What other factors increase my risk of fracture?
- And what can we do now to preserve or improve my bone health?
That may mean a DXA scan. It may mean calculating fracture risk. It may mean reviewing medications, nutrition, exercise, thyroid or other endocrine conditions, menstrual and reproductive history, or previous fractures. It may mean considering menopausal hormone therapy—or an osteoporosis-specific medication—or simply establishing a baseline and monitoring over time. There is no single bone-health prescription that fits every woman.
Midlife is an opportunity to think ahead
Bone loss associated with menopause is not something women can always prevent through diet and exercise alone. But identifying risk early can give us more options. The goal isn’t to become preoccupied with a number on a DXA report. It is to preserve mobility, strength and independence for the decades ahead.
Dr. Queen works with women to look at menopause in the context of the whole person—including hormones, metabolic health, nutrition, cardiovascular risk, muscle and bone health. If you’re entering perimenopause, approaching menopause, or wondering what your bone-density results actually mean, a personalized conversation can help clarify where you stand and what makes sense for you. Your bones are building your future. It’s worth knowing how they’re doing now. Call (415) 548-7901 to learn more and to schedule your appointment today.
STAY IN THE LOOP



